Ss Innovations International, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
SS Innovations International, Inc. filed an amendment to its 2025 annual report to include a new executive compensation clawback policy and updated certifications.
NASDAQ
SS Innovations International's 2024 10-K filing reveals a significant revenue increase driven by surgical robotic system sales, but also highlights substantial doubt about the company's ability to continue as a going concern due to recurring losses and dependence on external funding.
NASDAQ
SS Innovations International filed an amendment to its annual report to correct a typographical error and restate prior financials due to errors in merger accounting, functional classifications, revenue recognition, and lease accounting.
NASDAQ
SS Innovations International has restated its financial statements for 2022 and 2023 due to material accounting errors and a change in auditors, revealing ineffective internal controls.
NASDAQ
SS Innovations International reports a significant increase in revenue for 2023, driven by sales of its SSi Mantra surgical robotic system, while also highlighting ongoing efforts in research and development and regulatory approvals.